Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion type Assertion NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_head.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion description "[It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_provenance.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion evidence source_evidence_literature NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_provenance.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion SIO_000772 17554795 NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_provenance.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion wasDerivedFrom befree-20140225 NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_provenance.
- NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_assertion wasGeneratedBy ECO_0000203 NP440937.RAMBe_6IPLsY4LPwWsT0VJitu8tJPIoW-ZMBqqhfygvv0130_provenance.